PUBLISHER: The Business Research Company | PRODUCT CODE: 1939190
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939190
Actigraphy devices are non-invasive wearable tools developed to monitor and record physical activity and rest patterns over extended periods. Their primary function is to assess sleep-wake cycles and physical activity levels by tracking movement, aiding in the diagnosis of sleep disorders and evaluation of circadian rhythm disruptions.
The main types of actigraphy devices include wearable and handheld variants. Wearable actigraphy devices are compact, lightweight sensors typically worn on the wrist, ankle, or attached to clothing. These devices are distributed through both online platforms and physical retail stores. They are used for monitoring sleep disorders, circadian rhythm disturbances, diagnosing insomnia and restless leg syndrome, among other applications. The primary end users include healthcare providers, research institutions, home care environments, and fitness and sports centers.
Tariffs are impacting the actigraphy devices market by increasing costs of imported sensors, microchips, batteries, wireless modules, and wearable housings used in wrist-worn and handheld actigraphy devices. Healthcare providers and device manufacturers in North America and Europe are most affected due to reliance on imported electronics, while Asia-Pacific faces higher costs in export-oriented wearable production. These tariffs are increasing device prices and limiting accessibility in homecare and research settings. However, they are also encouraging local electronics assembly, regional sourcing of components, and innovation in software-driven value enhancement.
The actigraphy devices market research report is one of a series of new reports from The Business Research Company that provides actigraphy devices market statistics, including actigraphy devices industry global market size, regional shares, competitors with a actigraphy devices market share, detailed actigraphy devices market segments, market trends and opportunities, and any further data you may need to thrive in the actigraphy devices industry. This actigraphy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The actigraphy devices market size has grown strongly in recent years. It will grow from $2.59 billion in 2025 to $2.81 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing prevalence of sleep disorders, growing awareness of circadian rhythm health, expansion of sleep research studies, rising use of wearable health devices, growing demand for non-invasive diagnostics.
The actigraphy devices market size is expected to see strong growth in the next few years. It will grow to $3.9 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring, rising integration of actigraphy in digital health platforms, expansion of personalized sleep therapy solutions, growing use of actigraphy in clinical trials, increasing focus on preventive sleep health management. Major trends in the forecast period include increasing adoption of wearable sleep monitoring devices, rising integration of actigraphy with mobile health apps, growing demand for long-term sleep tracking solutions, expansion of clinical and home-based monitoring use, enhanced focus on data accuracy and patient compliance.
The increasing prevalence of sleep disorders is expected to drive the growth of the actigraphy devices market in the coming years. Sleep disorders are conditions that interfere with the quality, timing, or duration of sleep, negatively impacting overall health and daily functioning. These disorders are on the rise due to the growing amount of screen time, which disrupts the body's natural circadian rhythms by suppressing melatonin production from prolonged exposure to blue light. Actigraphy devices are essential for addressing sleep disorders, as they provide continuous, non-invasive monitoring of sleep-wake patterns over extended periods, offering objective data to support accurate assessments and treatment planning. For example, in November 2023, the National Health Service (NHS), a UK-based public healthcare system, reported that 37.8% of children aged 8 to 16 experienced sleep issues at least three times in the previous week. Additionally, sleep problems were reported by 76.5% of individuals with likely mental disorders and 25.0% of those without them. Therefore, the rising prevalence of sleep disorders is expected to drive the growth of the actigraphy devices market.
Companies operating in the actigraphy devices market are focusing on developing advanced products, such as multisensor wearable devices, for continuous, hands-free health monitoring. Multisensor wearable devices are sophisticated wearables equipped with multiple sensors that monitor various physiological and environmental parameters, such as movement, heart rate, temperature, and sleep patterns, simultaneously. For instance, in November 2023, ActiGraph LLC, a U.S.-based digital health company, launched the ActiGraph LEAP, a multisensor wearable. The ActiGraph LEAP includes a comprehensive set of sensors that allow for continuous monitoring of physical activity, sleep, mobility, and vital signs all in one device. Designed to meet the evolving needs of treatment effectiveness demonstrations, the device sets a new standard for patient-centered digital measurement. Its six integrated sensors track over 25 distinct digital health measures, including heart rate, oxygen saturation, blood pressure, skin temperature, activity, sleep, and gait data. The device seamlessly uploads data to the CentrePoint platform, where advanced, validated algorithms are used to process the information and provide accurate insights.
In February 2024, Cambridge Cognition Holdings plc, a UK-based developer and marketer of digital brain-health assessment solutions, formed a strategic partnership with ActiGraph. Through this collaboration, the companies aim to integrate Cambridge Cognition's validated digital cognitive and speech assessments with ActiGraph's actigraphy-based wearables and Accelerant digital health technology platform. The partnership is designed to accelerate the adoption of multi-modal digital measurements in central nervous system (CNS) trials, providing a more comprehensive view of patients' mental and physical capabilities and enhancing the sensitivity and efficiency of CNS drug development within the actigraphy devices market. ActiGraph is a U.S.-based provider of medical-grade actigraphy wearables and digital health technology solutions for clinical research.
Major companies operating in the actigraphy devices market are Koninklijke Philips N.V., ResMed Inc., Nox Health, VIVISOL SRL, Compumedics Limited, Empatica Inc., Cidelec, Cleveland Medical Devices Inc., Advanced Brain Monitoring Inc., CAMNTECH Limited, ActivInsights Ltd., Mini Mitter Co., Condor Instruments, SOMNOmedics GmbH, Itamar Medical Ltd., Neurosoft Ltd., BioSerenity, ActiGraph LLC, Philips Respironics, SleepScore Labs
North America was the largest region in the actigraphy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actigraphy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the actigraphy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The actigraphy devices market consists of sales of sleep monitoring systems, charging docks and cables, calibration tools, carrying cases and protective covers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Actigraphy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses actigraphy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for actigraphy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The actigraphy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.